保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Recurso digital |
| 言語: | |
| 出版事項: |
Zenodo
2025
|
| オンライン･アクセス: | https://doi.org/10.5281/zenodo.14990837 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
目次:
- <p>Metastasis is the major cause of death from cancer and metastasis to the lung in breast cancer is difficult to treat and heterogeneous in nature, complicating its management (1-5). We recently utilized whole transcriptome technologies to define the full complement of differentially expressed kinases and phosphatases in HER2+ breast cancer: in the primary tumor, and in metastasis to the CNS (6-8). Here we utilize whole transcriptome technologies (9, 10) to measure total transcription in the lung metastases of humans with breast cancer. We identify here a therapeutic target based on its differential expression and up-regulation upon metastasis to the lung in humans with breast cancer, PPP1R9A, as a candidate therapeutic target for the medical management of lung metastasis. </p>